Epigenetic agents in combined anticancer therapy

Z Kejík, M Jakubek, R Kaplánek, J Králová… - Future Medicinal …, 2018 - Taylor & Francis
In the last decade, epigenetic drugs (such as inhibitors of DNA methyltransferases and
histone deacetylases) have been intensively used for cancer treatment. Their applications …

[HTML][HTML] Epigenetic Landscapes of Pain: DNA Methylation Dynamics in Chronic Pain

HY Xiong, A Wyns, JV Campenhout, J Hendrix… - International Journal of …, 2024 - mdpi.com
Chronic pain is a prevalent condition with a multifaceted pathogenesis, where epigenetic
modifications, particularly DNA methylation, might play an important role. This review delves …

Detection of epigenetic aberrations in the development of hepatocellular carcinoma

Y Zhang - … Risk Assessment, Diagnosis, Treatment, and Prognosis, 2015 - Springer
Hepatocellular carcinoma (HCC) is the third most common cause of cancer death
worldwide. Hepatocarcinogenesis is a complex, multistep process. It is now recognized that …

[HTML][HTML] Hepatitis C virus eradication in people living with human immunodeficiency virus: Where are we now?

AM Spera, P Pagliano, V Conti - World Journal of Hepatology, 2024 - ncbi.nlm.nih.gov
Hepatitis C virus (HCV)/human immunodeficiency virus (HIV) co-infection still involves 2.3
million patients worldwide of the estimated 37.7 million living with HIV, according to World …

Epigenetic and epigenomic mechanisms shape sarcoma and other mesenchymal tumor pathogenesis

IM Bennani-Baiti - Epigenomics, 2011 - Taylor & Francis
Sarcomas comprise a large number of rare, histogenetically heterogeneous, mesenchymal
tumors. Cancers such as Ewing's sarcoma, liposarcoma, rhabdomyosarcoma and synovial …

Evaluating the consistency of gene methylation in liver cancer using bisulfite sequencing data

X Zheng, Q Wu, H Wu, KS Leung, MH Wong… - Frontiers in cell and …, 2021 - frontiersin.org
Bisulfite sequencing is considered as the gold standard approach for measuring DNA
methylation, which acts as a pivotal part in regulating a variety of biological processes …

Downregulation of miR‐221 inhibits cell migration and invasion through targeting Methyl‐CpG binding domain protein 2 in human oral squamous cell carcinoma cells

S He, R Lai, D Chen, W Yan, Z Zhang… - BioMed research …, 2015 - Wiley Online Library
Oral squamous cell carcinoma (OSCC), the most frequent of all oral cancers, is a type of
highly malignant tumors with a high capacity to invade locally and form distant metastases …

E2F6/KDM5C promotes SF3A3 expression and bladder cancer progression through a specific hypomethylated DNA promoter

KL Liu, YW Yin, BS Lu, YL Niu, DD Wang, B Shi… - Cancer Cell …, 2022 - Springer
Background Abnormal expression of splicing factor 3A subunit 3 (SF3A3), a component of
the spliceosome, has been confirmed to be related to the occurrence and development of …

Novel tumor suppressor SPRYD4 inhibits tumor progression in hepatocellular carcinoma by inducing apoptotic cell death

KR Zahid, S Han, F Zhou, U Raza - Cellular Oncology, 2019 - Springer
Background Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-
associated deaths worldwide. Although recent studies have proposed different biomarkers …

The association between methylation patterns of DNAH17 and clinicopathological factors in hepatocellular carcinoma

X Fan, H Guo, B Dai, L He, D Zhou, H Lin - Cancer Medicine, 2019 - Wiley Online Library
Background Hepatocellular carcinoma (HCC) is a malignancy with poor prognosis. Complex
genetic and epigenetic alterations are the two primary causes of HCC. The aim of the study …